A growing body of evidence shows the participation of tau pathology in many features of Parkinson’s disease, such as the aberrant hyperphosphorylation of tau protein, the presence in about 50% of PD patient brains of tau aggregates, which can be transported between neurons, and the tau/α-synuclein interaction [32]. This evidence concerns the gene MAPT and Parkinson disease.